| MCYAX | VEMAX | MCYAX / VEMAX | |
| Total Expense Ratio | 1.35 | 0.13 | 1,038% |
| Annual Report Gross Expense Ratio | 1.58 | 0.13 | 1,215% |
| Fund Existence | 8 years | 19 years | - |
| Gain YTD | 34.208 | 25.274 | 135% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 15000 | 3000 | 500% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 118M | 141B | 0% |
| Annual Yield % from dividends | 0.20 | 2.75 | 7% |
| Returns for 1 year | 33.92 | 22.65 | 150% |
| Returns for 3 years | 58.99 | 52.26 | 113% |
| Returns for 5 years | 22.24 | 28.78 | 77% |
| Returns for 10 years | N/A | 91.07 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ACVRX | 11.38 | -0.05 | -0.44% |
| American Century International Val R | |||
| JFNSX | 76.55 | -0.39 | -0.51% |
| Janus Henderson Global Life Sciences S | |||
| CSIIX | 8.69 | -0.06 | -0.69% |
| Copeland International Small Cap I | |||
| LICAX | 18.43 | -0.23 | -1.23% |
| Lord Abbett International Equity A | |||
| OSTFX | 20.58 | -0.30 | -1.44% |
| Osterweis | |||